Dyslipidemias have emerged as prevalent disorders among patients, posing significant risks
for the development and progression of cardiovascular diseases. These conditions are …

The oleaginous fungus Mortierella alpina has distinct advantages in long-chain PUFAs
production, and it is the only source for dietary arachidonic acid (ARA) certificated by FDA …

Cardiovascular disease (CVD) is still a leading cause of morbidity and mortality, despite all
the progress achieved as regards to both prevention and treatment. Having high levels of …

The pathogenesis of coronary heart disease is a highly complex process, with lipid
metabolism disorders being closely linked to its development. Therefore, this paper …

Background Dyslipidemia/hyperlipidemia are among the risk factors for chronic diseases,
especially cardiovascular diseases. Red Yeast Rice (RYR) herbal supplement may be …

Introduction: Clinical trials are the gold standard for testing new therapies. Databases like
ClinicalTrials. gov provide access to trial information, mainly covering the US and Europe. In …

Aim: Low-density lipoprotein cholesterol (LDL-C) level reduction is highly effective in
preventing the occurrence of a cardiovascular event. Contrariwise, an inverse association …

Background. Dyslipidemia has become a critical global issue for public health, with
elevating prevalence and morbidity closely related to many cardiovascular diseases (CVD) …

Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide, primarily
affecting the heart and blood vessels, with atherosclerosis being a major contributing factor …

Atherosclerotic cardiovascular disease (ASCVD) has become the leading cause of death
worldwide, and early diagnosis and treatment of atherosclerosis (AS) are crucial for …